OCA
IMVT icon

Octagon Capital Advisors’s Immunovant IMVT Stock Holding History

Octagon Capital Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-273,289
Closed -$8.83M – 53
2024
Q1 		$8.83M Hold
273,289
– – 1.07% 27
2023
Q4 		$11.5M Buy
+273,289
New +$10.1M 1.84% 14
2023
Q3 		– Hold
0
– – – 43
2022
Q4 		– Sell
-579,061
Closed -$3.23M – 41
2022
Q3 		$3.23M Hold
579,061
– – 0.56% 26
2022
Q2 		$2.26M Sell
579,061
-895,939
-61% -$3.87M 0.6% 16
2022
Q1 		$8.13M Buy
1,475,000
+902,138
+157% +$5.62M 1.76% 16
2021
Q4 		$4.88M Buy
+572,862
New +$4.73M 0.95% 20

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
AGM
Alpine Global Management New York $658M AUM 20.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return